Agitation: Clinical Trials

9 trials for Agitation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 2, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 9
Phase 34Completed 4

Follow Agitation: new trials by email Literature Review of Agitation trials Research Report on Agitation

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
T2:C100, Placebo - Agitation, Dementia
Phase 2CompletedUniversity of Southern California1202024-01-052026-09-02
Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children
Dexmedetomidine, saline - Agitation
Phase 2 / Phase 3CompletedAssiut University902016-05-012020-07-14
Safety and Efficacy of Nabilone in Alzheimer's Disease
Nabilone, Placebo - Alzheimer Disease, Agitation
Phase 2 / Phase 3CompletedSunnybrook Health Sciences Centre382015-01-012020-06-25
Treatment of Psychosis and Agitation in Alzheimer's Disease
Lithium, Placebo - Alzheimer's Disease, Psychosis
Phase 2CompletedNew York State Psychiatric Institute772014-06-012024-05-02
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease
AVP-923-20, Placebo, AVP-923-30 - Agitation, Alzheimer's Disease
Phase 2CompletedAvanir Pharmaceuticals2202012-08-132021-11-26
Pain in Patients With Dementia and Behavioural Disturbances
Paracetamol, Morphine, Buprenorphine plaster - Dementia, Pain
Phase 2 / Phase 3CompletedUniversity of Bergen3522009-11-012011-08-10
A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia
Intramuscular Haloperidol, Intramuscular Levosulpiride - Agitation
Phase 2 / Phase 3CompletedShanghai Mental Health Center2402009-02-012010-12-03
Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium
Dexmedetomidine, Standard of Care - Delirium, Agitation
Phase 2CompletedBrigham and Women's Hospital532006-01-012017-06-09
A Comparison of Dexmedetomidine and Haloperidol in Patients With Intensive Care Unit (ICU)-Associated Agitation and Delirium
dexmedetomidine, haloperidol - Delirium, Agitation
Phase 2CompletedAustin Health202005-01-012013-01-24

Narrower conditions

Psychomotor Agitation (9)  ·  Alzheimer Disease (4)  ·  Aggression (2)  ·  Delirium (2)  ·  Dementia (2)  ·  Pain (2)  ·  Agnosia (1)  ·  Delusions (1)  ·  Hallucinations (1)  ·  Psychotic Disorders (1)  ·  Respiratory Aspiration (1)  ·  Schizophrenia (1)  ·  Weight Loss (1)

Broader conditions

Aberrant Motor Behavior in Dementia (9)  ·  Behavior (9)  ·  Behavioral Symptoms (9)  ·  Dyskinesias (9)  ·  Nervous System Diseases (9)  ·  Neurobehavioral Manifestations (9)  ·  Neurologic Manifestations (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Psychomotor Disorders (9)  ·  Signs and Symptoms (9)  ·  Mental Disorders (8)  ·  Neurocognitive Disorders (7)  ·  Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Neurodegenerative Diseases (4)

Interventions

Dexmedetomidine (3)  ·  Acetaminophen (1)  ·  Haloperidol (1)  ·  Lithium (1)  ·  Lithium Carbonate (1)  ·  Morphine (1)  ·  Pregabalin (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Standard of Care (1)  ·  dextromethorphan - quinidine combination (1)  ·  nabilone (1)

Sponsors

Assiut University (1)  ·  Austin Health (1)  ·  Avanir Pharmaceuticals (1)  ·  Brigham and Women's Hospital (1)  ·  New York State Psychiatric Institute (1)  ·  Shanghai Mental Health Center (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  University of Bergen (1)  ·  University of Southern California (1)

Countries

United States (4)  ·  Canada (1)  ·  China (1)  ·  Egypt (1)  ·  Norway (1)

Top investigators

Bettina S. Husebo, MD, PhD (1)  ·  Brigid Reynolds, NP (1)  ·  Clive Ballard, MD, PhD (1)  ·  DP Devanand, MD (1)  ·  Dag Aarsland, MD, Phd (1)  ·  Gerald L Weinhouse, MD (1)  ·  Huafang LI, MD,PhD (1)  ·  Jacobo Mintzer, MD (1)  ·  Michael C Reade, MBBS FJFICM (1)  ·  Nathan Herrmann, MD (1)  ·  Paul Aisen, MD (1)  ·  Rinaldo Bellomo, MD FJFICM (1)  ·  Rolv Terje Lie, PhD (1)

Results publications

PMID 19454032, PMID 21765198, PMID 23611363, PMID 24806873, PMID 27247487, PMID 27524403, PMID 29136228, PMID 29859917, PMID 30753761, PMID 31182351, PMID 31322567, PMID 31547752, PMID 31672419, PMID 34059401, PMID 34532852, PMID 37732619, PMID 40562636

NIH funding

2008 (1), R01AG047146 (1), R01AG068324 (1), R01AG095004 (1)